Biopolymeric micro and nanoscale colloidal delivery systems for controlled drug release in pharmaceutical sector

Controlled release delivery systems have become a focal point in the pharmaceutical sector, with biopolymers playing a crucial role in enabling precise modulation of active compound release. Polymers, categorized into natural and synthetic types, are widely used due to their biocompatibility, biodegradability, and versatility. Natural biopolymers, such as proteins, polysaccharides, and microbial polyesters, offer high bioactivity but may encounter challenges related to mechanical strength and degradation rates. Synthetic polymers, including poly(lactic acid) and polycaprolactone, are engineered to provide enhanced stability and tunable release profiles. Integrating these biopolymers in controlled release systems enhances targeted therapeutic outcomes by ensuring sustained drug release in pharmaceutical applications, thereby improving drug efficacy and minimising side effects. This review demonstrates that utilizing novel approaches involving biopolymeric materials for controlled-release delivery systems is a promising route for precise control, offering important industrial potential. Integrating these materials in the pharmaceutical industry represents a breakthrough in enhancing release profiles and targeting specific applications (e.g. cancer therapy, drug delivery, nutraceutical delivery). The latest advancements in biopolymeric materials and their applications in controlled release systems, focusing on targeted release strategies, are comprehensively discussed. Key release mechanisms (diffusion, erosion, and swelling) are also critically compared for targeted applications. Despite progress, challenges like scalability and in vivo validation require further research to bridge lab-scale innovations to commercial applications. Biopolymeric delivery systems enable controllable release kinetics through material-structure interactions, supporting rational design of targeted pharmaceutical formulations with translational relevance.

Authors

Institutions

Publication Details

Journal
Bioresource Technology
Published
2026-04-13
DOI
https://doi.org/10.1016/j.biortech.2026.134626
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biopolymeric micro and nanoscale colloidal delivery systems for controlled drug release in pharmaceutical sector

Dan Cristian Vodnar, Lavinia-Florina Calinoiu, Gheorghe-Adrian Martau, Razvan Odocheanu
Bioresource Technology
Advanced Drug Delivery Systems
article

Biopolymeric micro and nanoscale colloidal delivery systems for controlled drug release in pharmaceutical sector

Dan Cristian Vodnar, Lavinia-Florina Calinoiu, Gheorghe-Adrian Martau, Razvan Odocheanu
article en

Abstract

Controlled release delivery systems have become a focal point in the pharmaceutical sector, with biopolymers playing a crucial role in enabling precise modulation of active compound release. Polymers, categorized into natural and synthetic types, are widely used due to their biocompatibility, biodegradability, and versatility. Natural biopolymers, such as proteins, polysaccharides, and microbial polyesters, offer high bioactivity but may encounter challenges related to mechanical strength and degradation rates. Synthetic polymers, including poly(lactic acid) and polycaprolactone, are engineered to provide enhanced stability and tunable release profiles. Integrating these biopolymers in controlled release systems enhances targeted therapeutic outcomes by ensuring sustained drug release in pharmaceutical applications, thereby improving drug efficacy and minimising side effects. This review demonstrates that utilizing novel approaches involving biopolymeric materials for controlled-release delivery systems is a promising route for precise control, offering important industrial potential. Integrating these materials in the pharmaceutical industry represents a breakthrough in enhancing release profiles and targeting specific applications (e.g. cancer therapy, drug delivery, nutraceutical delivery). The latest advancements in biopolymeric materials and their applications in controlled release systems, focusing on targeted release strategies, are comprehensively discussed. Key release mechanisms (diffusion, erosion, and swelling) are also critically compared for targeted applications. Despite progress, challenges like scalability and in vivo validation require further research to bridge lab-scale innovations to commercial applications. Biopolymeric delivery systems enable controllable release kinetics through material-structure interactions, supporting rational design of targeted pharmaceutical formulations with translational relevance.

Bioresource TechnologyVol. 452
University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca (RO)
Ministerul Cercetării, Inovării şi Digitalizării, Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii, HORIZON EUROPE Framework Programme, H2020 Marie Skłodowska-Curie Actions, HORIZON EUROPE Marie Sklodowska-Curie Actions
Industry, innovation and infrastructure
Openalex Percentile: Top 19%
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.